Welcome to medications.com

Ceragenix Commences Second in Series of Clinical Trials - Business Wire (press release)

The Company recently announced results from a 113 person clinical study that compared EpiCeramā„¢ to CutivateĀ®, a topical mid-strength steroid in treating the ...

http://home.businesswire.com/port... | Posted: Wed Apr 25 04:54:57 -0400 2007




Frequently Reported Side Effects of Cutivate

© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com